Allspring Global Investments’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-19,353
| Closed | -$613K | – | 1794 |
|
2025
Q1 | $613K | Sell |
19,353
-1,356
| -7% | -$43K | ﹤0.01% | 1388 |
|
2024
Q4 | $754K | Sell |
20,709
-2,996
| -13% | -$109K | ﹤0.01% | 1357 |
|
2024
Q3 | $739K | Sell |
23,705
-10,702
| -31% | -$334K | ﹤0.01% | 1392 |
|
2024
Q2 | $920K | Sell |
34,407
-1,930
| -5% | -$51.6K | ﹤0.01% | 1350 |
|
2024
Q1 | $1.24M | Sell |
36,337
-303
| -0.8% | -$10.3K | ﹤0.01% | 1312 |
|
2023
Q4 | $1.06M | Sell |
36,640
-2,943
| -7% | -$85.2K | ﹤0.01% | 1327 |
|
2023
Q3 | $1.09M | Sell |
39,583
-15,596
| -28% | -$430K | ﹤0.01% | 1339 |
|
2023
Q2 | $1.66M | Sell |
55,179
-36,691
| -40% | -$1.1M | ﹤0.01% | 1291 |
|
2023
Q1 | $3.33M | Buy |
91,870
+30,611
| +50% | +$1.11M | 0.01% | 1102 |
|
2022
Q4 | $2.19M | Buy |
61,259
+51,613
| +535% | +$1.84M | ﹤0.01% | 1212 |
|
2022
Q3 | $326K | Buy |
9,646
+7,170
| +290% | +$242K | ﹤0.01% | 1676 |
|
2022
Q2 | $71K | Sell |
2,476
-59,513
| -96% | -$1.71M | ﹤0.01% | 2153 |
|
2022
Q1 | $2M | Sell |
61,989
-3,511
| -5% | -$113K | ﹤0.01% | 1498 |
|
2021
Q4 | $1.91M | Buy |
+65,500
| New | +$1.91M | ﹤0.01% | 1553 |
|